Transcriptional activation of signal transducer and activator of transcription (STAT) 3 and STAT5B partially mediate homeobox A1-stimulated oncogenic transformation of the immortalized human mammary epithelial cell

Endocrinology

Volumn 149, Issue 5, 2008, Pages 2219-2229

  Mohankumar, Kumarasamypet M ^a   Perry, Jo K ^a   Kannan, Nagarajan ^a   Kohno, Kimitoshi ^c   Gluckman, Peter D ^a   Emerald, B Starling ^a   Lobie, Peter E ^a,b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b THE UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STAT3 PROTEIN; STAT5A PROTEIN; STAT5B PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HOXA1; UNCLASSIFIED DRUG;

ARTICLE; BREAST EPITHELIUM; CARCINOGENESIS; CARCINOGENICITY; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION INITIATION; UPREGULATION;

CELL LINE, TRANSFORMED; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; MAMMARY GLANDS, HUMAN; MODELS, BIOLOGICAL; PHOSPHORYLATION; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSFECTION; UP-REGULATION;

EID: 42449141532     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-1320     Document Type: Article

References (55)

1. Lewis EB 1978 A gene complex controlling segmentation in Drosophila. Nature 276:565-570
2. Abate-Shen C 2002 Deregulated homeobox gene expression in cancer: cause or consequence? Nat Rev Cancer 2:777-785
3. Zhang X, Zhu T, Chen Y, Mertani HC, Lee K-O, Lobie PE 2003 Human growth hormone-regulated HOXA1 is a human mammary epithelial oncogene. J Biol Chem 278:7580-7590
4. Mohankumar KM, Xu XQ, Zhu T, Kannan N, Miller LD, Liu ET, Gluckman PD, Sukumar S, Emerald BS, Lobie PE 2007 HOXA1-stimulated oncogenicity is mediated by selective upregulation of components of the p44//42 MAP kinase pathway in human mammary carcinoma cells. Oncogene 26:3998-4008
5. Zhu T, Starling-Emerald B, Zhang X, Lee K-O, Gluckman PD, Mertani HC, Lobie PE 2005 Oncogenic transformation of human mammary epithelial cells by autocrine human growth hormone. Cancer Res 65:317-324
6. Zhu T, Goh ELK, Graichen R, Ling L, Lobie PE 2001 Signal transduction via the growth hormone receptor. Cell Signal 13:599-616
7. Calò V, Migliavacca M, Bazan V, Macaluso M, Buscemi M, Gebbia N, Russo A 2003 STAT proteins: from normal control of cellular events to tumorigenesis. J Cell Physiol 197:157-168
8. Bromberg J, Darnell Jr JE2000 The role of STATs in transcriptional control and their impact on cellular function. Oncogene 19:2468-2473
9. Yu H, Jove R 2004 The STATs of cancer-new molecular targets come of age. Nat Rev Cancer 4:97-105
10. Garcia R, Jove R 1998 Activation of STAT transcription factors in oncogenic tyrosine kinase signaling. J Biomed Sci 5:79-85
11. Garcia R, Yu CL, Hudnall A, Catlett R, Nelson KL, Smithgall T, Fujita DJ, Ethier SP, Jove R 1997 Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. Cell Growth Differ 8:1267-1276
12. Nevalainen MT, Xie J, Torhorst J, Bubendorf L, Haas P, Kononen J, Sauter G, Rui H 2004 Signal transducer and activator of transcription-5 activation and breast cancer prognosis. J Clin Oncol 22:2053-2060
13. Bowman T, Garcia R, Turkson J, Jove R 2000 STATs in oncogenesis. Oncogene 19:2474-2488
14. Mertani HC, Zhu T, Goh EL, Lee KO, Morel G, Lobie PE 2001 Autocrine human growth hormone (hGH) regulation of human mammary carcinoma cell gene expression. Identification of CHOP as a mediator of hGH-stimulated human mammary carcinoma cell survival. J Biol Chem 276:21464-21475
15. Ling L, Lobie PE 2004 RhoA/ROCK activation by growth hormone abrogates p300/histone deacetylase 6 repression of Stat5-mediated transcription. J Biol Chem 279:32737-32750
16. Zhu Z, Mukhina S, Zhu T, Mertani HC, Lee K-O, Lobie PE 2005 p44/42 MAP kinase-dependent regulation of catalase by autocrine human growth hormone protects human mammary carcinoma cells from oxidative stress-induced apoptosis. Oncogene 24:3774 -3785
17. Kaulsay KK, Zhu T, Bennett WF, Lee K-O, Lobie PE 2001 The effects of autocrine human growth hormone (hGH) on human mammary carcinoma cell behavior are mediated via the hGH receptor. Endocrinology 142:767-777
18. Zhang X, Emerald BS, Mukhina S, Mohankumar KM, Kraemer A, Yap AS, Gluckman PD, Lee K-O, Lobie PE 2006 HOXA1 is required for E-cadherin-dependent anchorage-independent survival of human mammary carcinoma cells. J Biol Chem 281:6471-6481
19. Debnath J, Muthuswamy SK, Brugge JS 2003 Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30:256-268
20. Fuge EK, Braun EL, Werner-Washburne M 1994 Protein synthesis in long-term stationary-phase cultures of Saccharomyces cerevisiae. J Bacteriol 176:5802-5813
21. Hayashi S, Scott MP 1990 What determines the specificity of action of Drosophila homeodomain proteins? Cell [Erratum (1991) 64:1046] 63:883-894
22. Kato K, Nomoto M, Izumi H, Ise T, Nakano S, Niho Y, Kohno K 2000 Structure and functional analysis of the human STAT3 gene promoter: alteration of chromatin structure as a possible mechanism for the upregulation in cisplatin-resistant cells. Biochim Biophys Acta 1493:91-100
23. Crispi S, Sanzari E, Monfregola J, De Felice N, Fimiani G, Ambrosio R, D'Urso M, Ursini MV 2004 Characterization of the human STAT5A and STAT5B promoters: evidence of a positive and negative mechanism of transcriptional regulation. FEBS Lett 562:27-34
24. Ihle JN, Kerr IM 1995 Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet 11:69-74
25. Gouilleux F, Wakao H, Mundt M, Groner B 1994 Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription. EMBO J 13:4361-4369
26. Zhang X, Darnell Jr JE2001 Functional importance of Stat3 tetramerization in activation of the alpha 2-macroglobulin gene. J Biol Chem 276:33576-33581
27. Nakajima K, Yamanaka Y, Nakae K, Kojima H, Ichiba M, Kiuchi N, Kitaoka T, Fukada T, Hibi M, Hirano T 1996 A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J 15:3651-3658
28. Wood TJ, Sliva D, Lobie PE, Goullieux F, Mui AL, Groner B, Norstedt G, Haldosen LA 1997 Specificity of transcription enhancement via the STAT responsive element in the serine protease inhibitor 2.1 promoter. Mol Cell Endocrinol 130:69-81
29. Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell Jr JE1999 Stat3 as an oncogene. Cell 98:295-303
30. Ariyoshi K, Nosaka T, Yamada K, Onishi M, Oka Y, Miyajima A, Kitamura T 2000 Constitutive activation of STAT5 by a point mutation in the SH2 domain. J Biol Chem 275:24407-24413
31. Bissell MJ, Rizki A, Mian IS 2003 Tissue architecture: the ultimate regulator of breast epithelial function. Curr Opin Cell Biol 15:753-762
32. Debnath J, Mills KR, Collins NL, Reginato MJ, Muthuswamy SK, Brugge JS 2002 The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell 111:29-40
33. Levy DE, Darnell JE 2002 STATS: transcriptional control and biological impact. Nat Rev Mol Cell Biol 3:651-662
34. Clarkson RW, Boland MP, Kritikou EA, Lee JM, Freeman TC, Tiffen PG, Watson CJ 2006 The genes induced by signal transducer and activators of transcription (STAT)3 and STAT5 in mammary epithelial cells define the roles of these STATs in mammary development. Mol Endocrinol 20:675-685
35. Liu X, Gallego MI, Smith GH, Robinson GW, Hennighausen L 1998 Functional release of Stat5a-null mammary tissue through the activation of compensating signals including Stat5b. Cell Growth Differ 9:795-803
36. Teglund S, McKay C, Schuetz E, van Deursen JM, Stravopodis D, Wang D, Brown M, Bodner S, Grosveld G, Ihle JN 1998 Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93:841-850
37. Besser D, Bromberg JF, Darnell Jr JE, Hanafusa H 1999 A single amino acid substitution in the v-Eyk intracellular domain results in activation of Stat3 and enhances cellular transformation. Mol Cell Biol 19:1401-1409
38. Bromberg JF, Horvath CM, Besser D, Lathem WW, Darnell Jr JE 1998 Stat3 activation is required for cellular transformation by v-src. Mol Cell Biol 18:2553-2558
39. Zong CS, Chan J, Levy DE, Horvath C, Sadowski HB, Wang L-H 2000 Mechanism of STAT3 activation by insulin-like growth factor I receptor. J Biol Chem 275:15099-15105
40. Zhang Y-W, Wang L-M, Jove R, Vande Woude GF 2002 Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis. Oncogene 21:217-226
41. Xi S, Zhang Q, Gooding WE, Smithgall TE, Grandis JR 2003 Constitutive activation of Stat5b contributes to carcinogenesis in vivo. Cancer Res 63:6763-6771
42. Sultan AS, Xie J, LeBaron MJ, Ealley EL, Nevalainen MT, Rui H 2004 Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells. Oncogene 24:746-760
43. Xi S, Zhang Q, Dyer KF, Lerner EC, Smithgall TE, Gooding WE, Kamens J, Grandis JR 2003 Src kinases mediate STAT growth pathways in squamous cell carcinoma of the head and neck. J Biol Chem 278:31574-31583
44. Yamashita H, Iwase H 2002 The role of Stat5 in estrogen receptor-positive breast cancer. Breast Cancer 9:312-318
45. Kazansky AV, Kabotyanski EB, Wyszomierski SL, Mancini MA, Rosen JM 1999 Differential effects of prolactin and src/abl kinases on the nuclear translocation of STAT5B and STAT5A. J Biol Chem 274:22484-22492
46. Buettner R, Mora LB, Jove R 2002 Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 8:945-954
47. Perry JK, Emerald BS, Mertani HC, Lobie PE 2006 The oncogenic potential of growth hormone. Growth Horm IGF Res 16:277-289
48. Lanning NJ, Carter-Su C 2006 Recent advances in growth hormone signaling. Rev Endocr Metab Disord 7:225-235
49. LeBaron M, Xie J, Rui H 2005 Evaluation of genome-wide chromatin library of Stat5 binding sites in human breast cancer. Mol Cancer 4:6
50. Hsieh F-C, Cheng G, Lin J 2005 Evaluation of potential Stat3-regulated genes in human breast cancer. Biochem Biophys Res Commun 335:292-299
51. Stephanou A, Brar BK, Knight RA, Latchman DS 2000 Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and Bcl-x promoters. Cell Death Differ 7:329-330
52. Nagy ZS, Rui H, Stepkowski SM, Karras J, Kirken RA 2006 A preferential role for STAT5, not constitutively active STAT3, in promoting survival of a human lymphoid tumor. J Immunol 177:5032-5040
53. Wang CX, Song JH, Song DK, Yong VW, Shuaib A, Hao C 2006 Cyclin-dependent kinase-5 prevents neuronal apoptosis through ERK-mediated upregulation of Bcl-2. Cell Death Differ 13:1203-1212
54. Kaulsay KK, Mertani HC, Lee KO, Lobie PE 2000 Autocrine human growth hormone enhancement of human mammary carcinoma cell spreading is Jak2 dependent. Endocrinology 141:1571-1584
55. Kaulsay KK, Mertani HC, Tornell J, Morel G, Lee KO, Lobie PE 1999 Autocrine stimulation of human mammary carcinoma cell proliferation by human growth hormone. Exp Cell Res 250:35-50